Bio-Techne TECH Protein Sciences — Operating Income
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bio-Techne in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Bio-Techne’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bio-Techne's protein sciences — operating income.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Bio-Techne's protein sciences — operating income?
- Bio-Techne (TECH) reported protein sciences — operating income of $100M in Q1 2026.
- How has Bio-Techne's protein sciences — operating income changed year-over-year?
- Bio-Techne's protein sciences — operating income decreased by 3.8% year-over-year, from $103.91M to $100M.
- What is the long-term trend for Bio-Techne's protein sciences — operating income?
- Over 4 years (2021 to 2025), Bio-Techne's protein sciences — operating income has grown at a 2.9% compound annual growth rate (CAGR), from $330.02M to $370.35M.
- What does protein sciences — operating income mean?
- The profit earned by the Protein Sciences segment from its core business operations.
- How do you interpret protein sciences — operating income?
- Higher operating income indicates strong operational efficiency and healthy profit margins for the segment.
- How does protein sciences — operating income compare across companies?
- Standard 'Segment Operating Income'; widely used by analysts to compare segment performance across competitors.